📜 Post with us on Reddit
📝 Create a new article
🏭 Create a company page
🇬🇧 - in English
🇫🇷 - en Français (FR)
🇵🇹 - em Português (PT)
🇩🇪 - auf Deutsch (DE)
🇯🇵 - 日本語で (JA)
Sponsored articles

You can edit almost every page by Creating an account and confirming your email.

James Duncan Carroll

From EverybodyWiki Bios & Wiki


  • Comment: This a WP:BLP, yet it reads like company article. Completely unsuitable as it stands at the moment. Non-standard layout, lacks references for WP:BIO article, promo and npov. I would reject it if there was more than one review. No indication of significance. Doesn't meet WP:NACADEMIC, nor WP:BIO. Fails WP:SIGCOV. scope_creepTalk 16:38, 19 July 2026 (UTC)


James Duncan Carroll
File:James Duncan Carroll.jpgJames_Duncan_Carroll.jpg James_Duncan_Carroll.jpg
James
Born(1962-05-07)May 7, 1962
United Kingdom
🏳️ NationalityBritish
🏫 EducationHarlow Technical College (Electronics)
💼 Occupation
Inventor, Author, Futurist, CEO
👔 EmployerTHOR Photomedicine Ltd.
Known forPhotobiomodulation (PBM), Low-level laser therapy (LLLT)
🏅 AwardsInnovation of the Year, Elite Sports Rehabilitation Expo (2016)
T.H. Maiman Award, Academy for Laser Dentistry (2021)
WALT Presidential Commendation (2020)

James Duncan Carroll (born 7 May 1962) is a British futurist, author, inventor, and medical device entrepreneur. He is the founder and CEO of THOR Photomedicine Ltd., a UK-based medical device company specialising in the design, manufacture, and clinical deployment of Photobiomodulation (PBM) therapy devices and Low-Level Laser Therapy (LLLT) equipment.[1][2][3]

With over 37 years of experience in photobiomodulation, Carroll has authored or co-authored 68 peer-reviewed PBM papers and contributed chapters to five PBM books, collaborating with academics across more than 50 institutions worldwide.[4] THOR's equipment has delivered more than 36 million treatments globally, and the company serves over 5,000 customers in more than 70 countries.[5]

THOR's clients include Harvard Medical School, the Wellman Center for Photomedicine at Massachusetts General Hospital, MIT, Brigham and Women's Hospital, the United States Navy, United States Special Forces, the Royal Air Force, the British Army, St. Jude Children's Research Hospital, Veterans' Hospitals, the UK National Health Service, Manchester United, and Nike, as well as professional sports leagues including the NFL, NBA, MLB, NHL, and UFC.[4][6]

Michael R. Hamblin, Professor at Harvard Medical School, Principal Investigator at the Wellman Center for Photomedicine, and editor-in-chief of the journal Photobiomodulation, Photomedicine and Laser Surgery, has described Carroll as "the world's leading ambassador for Low-Level Laser Therapy."[7][8]

Carroll is also a co-founder and investor in Lumithera Inc., a company developing PBM technologies for dry age-related macular degeneration and other ocular diseases.[4]

Early life

Carroll was born on 7 May 1962 in the United Kingdom. His birth and early life are chronicled in a memoir by his father, singer and entertainer Ronnie Carroll: Luck of the Irish: Powerful Saga of an Irish Family Arriving in England Just as World War II Is Declared (Xlibris Corporation, 2012).[9][10]

Carroll studied electronics at Harlow Technical College in Essex, UK. His journey from engineer technician to photobiomodulation inventor and advocate was later chronicled by Global Founders London.[6] Early in his career, Carroll struggled with an undiagnosed learning difficulty before channelling his focus into the emerging science of low-level laser therapy.[6]

Background: photobiomodulation

Photobiomodulation (PBM), previously known as low-level laser therapy (LLLT), was first discovered in 1967 by Hungarian physician Endre Mester (1903–1984) at the Semmelweis Medical University in Budapest, who observed that low-power ruby laser irradiation could stimulate hair regrowth and wound healing in mice.[11][12] Mester is known as the "Father of Photobiomodulation."[11] The field has since expanded to encompass over 12,000 publications and more than 1,800 randomised controlled trials.[5] Carroll became one of the field's foremost advocates and device developers, building on Mester's foundational work.

Career

THOR International Ltd (1992–2007)

Carroll began his professional career in the photobiomodulation industry as Managing Director of THOR International Ltd. from 1992 to 2007, an LLLT equipment company through which he gained extensive expertise in laser and LED device design, manufacture, and clinical deployment.[1][13][14]

THOR Photomedicine Ltd

Carroll founded THOR Photomedicine Ltd., which has grown into the world's leading PBM company. THOR is an ISO 13485:2016 certified medical device company.[2] The company holds regulatory clearances from four major bodies: the FDA (United States), CE (European Union), TGA (Australia), and NATO, making it the only PBM company in the world to hold all four simultaneously.[5] THOR is also listed on the US Government's GSA schedule and the eCAT procurement system.[5]

The company's THOR LX2.3 Photobiomodulation system holds CE mark indication for oral mucositis, tendinopathies, joint pain, neck pain, and back pain in the UK, EU, and Australia. It is also FDA Cleared in the United States for temporary relief of minor muscle and joint pain, stiffness, muscle spasms, and minor pain and stiffness associated with arthritis.[2]

Carroll's stated mission is: "Photobiomodulation (PBM Therapy) in every department of every hospital, every doctor's office (clinic) and every home."[5] His documented long-term personal goal is to have PBM established as a standard of care for 100 diseases in 100 countries by 7 May 2062 — his 100th birthday.[6]

THOR has established research partnerships with six Harvard Medical School research groups and more than 30 universities globally, contributing to over 51 academic papers.[15] Harvard collaborations have encompassed research into traumatic brain injury (TBI), oral mucositis as a side effect of cancer therapy, noise-induced hearing loss, and temporomandibular joint dysfunction.[16]

Carroll also works with 36 medical institutions — including Harvard Medical School, St. Jude Children's Research Hospital, Veterans' Hospitals, and the UK NHS — on using PBM for treating traumatic brain injury, cancer treatment side effects, acute and chronic pain, and reducing opioid use.[17][18]

Carroll took PBM therapy through the NICE guidance process in the United Kingdom; NICE now formally recommends PBM therapy for the prevention and treatment of oral mucositis in cancer patients.[19] The American College of Physicians also recommends PBM for low back pain.[19]

NovoTHOR Whole Body Light Pod

In 2016, Carroll unveiled the NovoTHOR Whole Body Light Pod at the Elite Sports Rehabilitation Expo in London, where it won the Innovation of the Year Award.[20][21] Described as the world's first whole-body photobiomodulation device operating within known effective clinical parameters,[20] NovoTHOR was developed to improve athletic performance and accelerate recovery. Nike subsequently purchased the device to support Nike-sponsored athletes in improving muscle power, reducing fatigue, and accelerating recovery after training.[6]

Dosage research and parameter reporting

In 2008, Carroll developed and published a comprehensive PBM Therapy dosage guide[22] and a separate analysis of LLLT dose-rate effects,[23] which became widely cited references in PBM research. He is a recognised authority on PBM dose, dose-rate effects, and the measurement and reporting of light therapy parameters.[4] In 2011, Carroll co-authored with Jenkins a formal methodology paper on how to report LLLT dose and beam parameters in clinical and laboratory studies, now a standard reference in the field.[24]

Awards and honours

  • 2016 – Innovation of the Year Award, Elite Sports Rehabilitation Expo, London, for the NovoTHOR Whole Body Light Pod[20]
  • 2020 – Presidential Commendation, World Association for Laser Therapy (WALT), for outstanding service and leadership in the field of photobiomodulation[25]
  • 2021 – T.H. Maiman Award for excellence in medical laser research, Academy for Laser Dentistry annual conference (April 8–10, 2021); presented by Kathleen Maiman, widow of laser inventor Theodore Maiman[17][26][27]

Positions held

  • Co-chair, Biomedical Optics Society conference on Photobiomodulation Mechanisms, SPIE (2009–present)[4][18]
  • Fellow of the Royal Society of Medicine (2009–present)[7][18]
  • Editorial Board, Photomedicine and Laser Surgery (2008–2013)[18]
  • Expert peer reviewer, PLOS ONE (Public Library of Science)[7]
  • Expert peer reviewer, Journal of Photochemistry and Photobiology, Biology[7]
  • Expert peer reviewer, Annals of Biomedical Engineering[7]
  • Expert peer reviewer, Photomedicine and Photochemistry[7]
  • World Association for Laser Therapy (WALT) – board member (2000–2004; 2016–present)[18]
  • North American Association for Laser Therapy (NAALT) – board member (2002–2006)[18]

Advocacy

United Nations (2014)

On 6 May 2014, Carroll addressed the United Nations Global Health Impact Forum in New York City, presenting on the science and promise of photobiomodulation therapy and its potential role in supporting the Millennium Development Goals.[28][29][6] Carroll stated: "Photobiomodulation has the potential to be in every department of every hospital and become part of standard care for many pathologies. Doctors just have to stop for a minute and think how many injuries and diseases would benefit from a bit less oxidative stress and a bit more ATP."[16]

U.S. House of Representatives (2018)

On 11 October 2018, Carroll briefed the United States House Committee on Science, Space, and Technology at the Rayburn House Office Building, Washington, D.C., on photobiomodulation as a drug-free pain treatment and its potential to reduce opioid dependence during the opioid epidemic in the United States.[15][30][31] Carroll also presented on PBM to policy advisors at the White House.[18]

NICE guidance (UK)

Carroll led THOR Photomedicine's engagement with the NICE guidance process in the United Kingdom. As a result, NICE now formally recommends PBM therapy for the prevention and treatment of oral mucositis in cancer patients undergoing chemotherapy and radiotherapy.[19][32]

Books

As author or co-author

  • Michael R. Hamblin; Cleber Ferraresi; Ying-Ying Huang; Lucas Freitas de Freitas; James D. Carroll (2018). Low-Level Light Therapy: Photobiomodulation. Tutorial Texts in Optical Engineering, vol. TT 115. SPIE Press. doi:10.1117/3.2295638. ISBN 978-1-5106-1415-4. Search this book on [33][34]

As contributing chapter author

Additionally, Carroll has co-authored nearly 70 peer-reviewed publications.[43]

References

  1. ↑ 1.0 1.1 "THOR PHOTOMEDICINE LIMITED – Overview". Companies House. Retrieved 2024-01-01.
  2. ↑ 2.0 2.1 2.2 "About THOR Photomedicine". thorlaser.com. Retrieved 2024-01-01.
  3. ↑ "System for Award Management – THOR Photomedicine". sam.gov. Retrieved 2024-01-01.
  4. ↑ 4.0 4.1 4.2 4.3 4.4 "James D. Carroll – SPIE Profile". SPIE. Retrieved 2024-01-01.
  5. ↑ 5.0 5.1 5.2 5.3 5.4 "Photobiomodulation (PBM Therapy) – THOR Laser". thorlaser.com. Retrieved 2024-01-01.
  6. ↑ 6.0 6.1 6.2 6.3 6.4 6.5 "THOR Photomedicine: The Making of an Icon". Global Founders London. 2016-07-29. Retrieved 2024-01-01.
  7. ↑ 7.0 7.1 7.2 7.3 7.4 7.5 "James Carroll – dentalaim.org". dentalaim.org. Retrieved 2024-01-01.
  8. ↑ "Advanced Laser Therapy Training Day". Physiotherapy New Zealand. Retrieved 2024-01-01.
  9. ↑ "Luck of the Irish by Ronnie Carroll – review". Kirkus Reviews. Retrieved 2024-01-01.
  10. ↑ Carroll, Ronnie (2012). Luck of the Irish: Powerful Saga of an Irish Family Arriving in England Just as World War II Is Declared. Xlibris Corporation. ISBN 978-1479706112. Search this book on
  11. ↑ 11.0 11.1 "Endre Mester". Wikipedia. Retrieved 2024-01-01.
  12. ↑ Mester, Andrew; Mester, Adam (2017). "The History of Photobiomodulation: Endre Mester (1903–1984)". Photobiomodulation, Photomedicine, and Laser Surgery. 35 (8): 393–394. doi:10.1089/pho.2017.4332. PMID 28783466.
  13. ↑ "THOR PHOTOMEDICINE LIMITED – Officers". Companies House. Retrieved 2024-01-01.
  14. ↑ "James Carroll – Biography" (PDF). THOR Photomedicine Ltd. Retrieved 2024-01-01.
  15. ↑ 15.0 15.1 "About THOR Photomedicine". novothor.com. Retrieved 2024-01-01.
  16. ↑ 16.0 16.1 "THOR Photomedicine Ltd Release: 'STAR TREK' Style Light Pod Wins Innovation of the Year". BioSpace. 2016-06-30. Retrieved 2024-01-01.
  17. ↑ 17.0 17.1 "James Carroll received the T.H. Maiman Award for outstanding research during the Academy for Laser Dentistry award ceremony". THOR Photobiomodulation Therapy Blog. Retrieved 2024-01-01.
  18. ↑ 18.0 18.1 18.2 18.3 18.4 18.5 18.6 "Conference 2021 – The Swallows Head and Neck Cancer". The Swallows. Retrieved 2024-01-01.
  19. ↑ 19.0 19.1 19.2 "James Carroll – THOR Blog". blog.thorlaser.com. Retrieved 2024-01-01.
  20. ↑ 20.0 20.1 20.2 "'STAR TREK' Style Light Pod Wins Innovation of the Year" (Press release). THOR Photomedicine Ltd. 2016-06-29. Retrieved 2024-01-01 – via PR Newswire.
  21. ↑ "'STAR TREK' Style Light Pod Wins Innovation of the Year" (Press release). Newswire. 2016-06-30. Retrieved 2024-01-01.
  22. ↑ "How Laser Therapy works – Dosage Guide". thorlaser.com. Retrieved 2024-01-01.
  23. ↑ "LLLT – Dose Rate Effects". blog.thorlaser.com. Retrieved 2024-01-01.
  24. ↑ Jenkins, PA; Carroll, JD (2011). "How to Report Low-Level Laser Therapy (LLLT)/Photomedicine Dose and Beam Parameters in Clinical and Laboratory Studies". Photomedicine and Laser Surgery. 29 (12): 785–787. doi:10.1111/j.1439-0531.2011.01948.x. PMID 22107087.
  25. ↑ "James Carroll 2020 WALT Presidential Commendation". THOR Photobiomodulation Therapy Blog. Retrieved 2024-01-01.
  26. ↑ "CSSP Spring 2019 Speaker, James Carroll, Honored". Council of Scientific Society Presidents. Retrieved 2024-01-01.
  27. ↑ "Conference 2021 Awards – The Swallows Head and Neck Cancer Charity". Retrieved 2024-01-01.
  28. ↑ "A Global Health Impact Forum – United Nations Department of Economic and Social Affairs". United Nations. Retrieved 2024-01-01.
  29. ↑ "Global Health Impact Forum: Health and technology to support the Millennium Development Goals". United Nations Web TV. Retrieved 2024-01-01.
  30. ↑ "EVENT: Ending Opioid Use – A New Hope". ASTRA (American Security & Technology Research Alliance). 10 November 2022. Retrieved 2024-01-01.
  31. ↑ "Ending Opioid Use". Washington DC Patch. 2018-09-26. Retrieved 2024-01-01.
  32. ↑ Adnan, Ather; Yaroslavsky, Anna N.; Carroll, James D.; Selting, Wayne; Juliano, Amy F.; London, Wendy B.; Sonis, Stephen T.; Duncan, Christine N.; Treister, Nathaniel S. (2021). "The Path to an Evidence-Based Treatment Protocol for Extraoral Photobiomodulation Therapy for the Prevention of Oral Mucositis". Frontiers in Oral Health. 2. doi:10.3389/froh.2021.689386. PMC 8757848 Check |pmc= value (help). PMID 35048034 Check |pmid= value (help). Unknown parameter |article-number= ignored (help)
  33. ↑ "Low-Level Light Therapy: Photobiomodulation". SPIE. Retrieved 2024-01-01.
  34. ↑ Hamblin, Michael R.; Ferraresi, Cleber; Huang, Ying-Ying; Freitas, Lucas Freitas; Carroll, James Duncan (November 2017). Low-Level Light Therapy: Photobiomodulation – Amazon. SPIE Press. ISBN 978-1510614154. Search this book on
  35. ↑ "Mechanisms of Photobiomodulation Therapy XIII". SPIE. Retrieved 2024-01-01.
  36. ↑ "Handbook of Photomedicine". CRC Press. Retrieved 2024-01-01.
  37. ↑ Hamblin, Michael R.; Huang, Ying-Ying (30 June 2020). Handbook of Photomedicine – Amazon. CRC Press. ISBN 978-0367576295. Search this book on
  38. ↑ "Handbook of Photomedicine – ResearchGate entry". researchgate.net. Retrieved 2024-01-01.
  39. ↑ Handbook of Low-Level Laser Therapy. Taylor & Francis / Pan Stanford. 14 October 2016. ISBN 978-981-4669-61-0. Retrieved 2024-01-01. Search this book on
  40. ↑ Hamblin, Michael R.; Agrawal, Tanupriya; Sousa, Marcelo de (26 August 2016). Handbook of Low-Level Laser Therapy – Amazon. Pan Stanford. ISBN 978-9814669603. Search this book on
  41. ↑ "Handbook of Low-Level Laser Therapy – Stanford University Library catalog". Stanford University. Retrieved 2024-01-01.
  42. ↑ "Handbook of Low-Level Laser Therapy – Book Review". Optics & Photonics News. January 2017. Retrieved 2024-01-01.
  43. ↑ "ORCID".

External links


This article "James Duncan Carroll" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:James Duncan Carroll. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.


Retrieved from "https://en.everybodywiki.com/index.php?title=James_Duncan_Carroll&oldid=6361625"
License CC BY-SA 3.0
Powered by MediaWiki